New plant will supply cell therapy products for late-stage clinical trials and future product launches / Supports clinical studies with BlueRock Therapeutics’ investigational cell therapy for Parkinson’s Disease bemdaneprocel (BRT-DA01) / New…
Berlin, Singapore, Allschwil 9-29-2023
Prof. Dr. Lars Schaade is the new President of the Robert Koch Institute. The 57-year-old physician had already been acting head of the Institute since 1 April, 2023.
Scientists have created a new zebrafish xenograft platform to screen for novel treatments for an aggressive brain tumor called glioblastoma, according to a new study by the Gerhardt and De Smet labs published in “EMBO Molecular Medicine.”
Application Deadline: Friday, 3 November, 2023 at 6pm (CET)
A team of researchers has uncovered a previously unknown compensatory mechanism found in liver disease. If Kupffer cells (KCs), a specific kind of immune cells found in the liver, become impaired by tissue scarring, immune cells originating in the…
Eckert & Ziegler AG has been awarded the Pankow 2023 Training Prize for outstanding training quality. The award was presented yesterday at a celebration event by Berlin-Pankow District Mayor Dr. Cordelia Koch.
After spending many years researching together, a group of scientists has founded CARTemis Therapeutics, a spin-off from the Max Delbrück Center. Uta Höpken, Armin Rehm, Anthea Wirges, and Mario Bunse want to use novel CAR T-cell therapies to help…
Collaboration will develop and market Satellite Hot Labs for radiolabeling of BioGuides
BeCAT - The therapy of the future is developed here
At Charité's "Berlin Center for Advanced Therapies" (BeCAT), the new class of Advanced Therapy Medicinal Products (ATMP) has been under development since 2018. In 2024, it will move into the new…
